Karol E. Watson, M.D., Ph.D., FACC  
Professor of Medicine/Cardiology
Director, UCLA Barbara Streisand Women’s Heart Health Program
Co-Director, UCLA Program in Preventative Cardiology
Director, UCLA Fellowship Program in Cardiovascular Diseases

VIDEO:
MAYO STAFF:  Access this pre-recorded session on the Video Exchange website.  
MAYO CLINIC CARE NETWORK:  You are being directed here from the video housed in the Care Network portal.

RELEASE:  January 27, 2016
EXPIRATION:  December 31, 2017 (Credit is not available after this expiration date.)

LEARNING OBJECTIVES:

  • Evaluate the safety profile of current and emerging lipid lowering therapies
  • Review the therapeutic effects of current and emerging lipid lowering therapies
  • Discuss the risks of current and emerging lipid lowering therapies

ACCREDITATION:
Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

Mayo Clinic College of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS:

  • Click the Take Course button below.
  • Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes will have 2-5 questions.
  • Complete the evaluation.  

TRANSCRIPT:
This credit will appear on your Transcript for permanent record.  To access your transcript, visit My Account, My Activities, RSS Transcript.

DISCLOSURE SUMMARY
As a provider accredited by ACCME, Mayo Clinic College of Medicine (Mayo School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities.  Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Medical Grand Rounds Planning Committee

Dr. Morie Gertz – Honoraria/Speaker’s Bureau/Grant Research Support:

•Isis
•Celgene
•Research to Practice
•Med Learning Group
•National Cancer Institute of Frederick
•Sandoz Inc (a Novartis Company)
•GlaxoSmithKline

Dr. Christina Dilaveri – None
Dr. Karna Sundsted – None
Dr. Amy Oxentenko – None
Dr. Christopher Stephenson – None
Dr. Brianna Vaa - None
Jeanine Kiefer – None

Medical Grand Rounds Advisory Group
Dr. Christina Dilaveri – None
Dr. Karna Sundsted – None
Dr. John Bundrick – None
Dr. Colin West – None
Dr. Aaron Mansfield – Honoraria: Celgene, Genentech; Grant/Research Support: NIH; Honoraria: Rockpointe CME
Dr. John Kisiel – Consultant/Grant/Research Support: Exact Sciences
Jeanine Kiefer – None

Presenter - Dr. Karol Watson - Consultant: Astra Zeneca, Daiichi Sankyo, GSK, Merck

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

QUESTIONS?
MAYO STAFF:   Contact Jeanine Kiefer at 8-1952.
MAYO CLINIC CARE NETWORK MEMBERS:  Contact cme@mayo.edu  

Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota